Global Prosthetic Heart Valve Devices And Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Type;

Transcatheter Heart Valve, Tissue Heart Valve and Mechanical Heart Valve.

By Product Type;

Repair Products, Mitral Valve Repair Devices, and Tricuspid Valve Repair Devices.

By Technology;

Biological Valve, and Decellularized Valve.

By Application;

Hospitals and Ambulatory Surgery Centres.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn133707720 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Prosthetic Heart Valve Devices And Equipment Market (USD Million), 2021 - 2031

In the year 2024, the Global Prosthetic Heart Valve Devices And Equipment Market was valued at USD 5,859.44 million. The size of this market is expected to increase to USD 10,655.00 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 8.9%.

The global prosthetic heart valve devices and equipment market is experiencing robust growth due to the increasing prevalence of heart valve diseases and the rising geriatric population. As cardiovascular diseases remain the leading cause of mortality worldwide, the demand for effective heart valve replacement solutions is escalating. Prosthetic heart valves, including mechanical valves, bioprosthetic valves, and transcatheter valves, are essential in treating various heart valve disorders such as aortic stenosis and mitral regurgitation. Technological advancements, particularly in minimally invasive procedures and the development of durable and biocompatible materials, have significantly improved patient outcomes and expanded the market.

Technological innovation is a key driver of the market. Advances in transcatheter aortic valve replacement (TAVR) procedures have revolutionized the treatment of aortic valve diseases, providing a less invasive alternative to traditional open-heart surgery. This has expanded the patient pool, including those who are at high or intermediate surgical risk. Additionally, ongoing research and development efforts are focused on enhancing the durability and performance of bioprosthetic valves, reducing the need for repeat procedures, and improving overall patient quality of life. The integration of imaging technologies and robotic-assisted surgeries further enhances precision and success rates in valve implantation procedures.

Geographically, North America and Europe dominate the prosthetic heart valve market due to well-established healthcare systems, high healthcare expenditure, and a large patient base. However, the Asia-Pacific region is emerging as a significant growth area, driven by increasing healthcare awareness, improving healthcare infrastructure, and a rising incidence of cardiovascular diseases. Market players are actively expanding their presence in these regions through strategic partnerships and product launches. Furthermore, supportive government initiatives and the increasing adoption of advanced medical technologies in developing countries present substantial growth opportunities. The global market is characterized by intense competition among leading companies, which are continuously striving to innovate and improve the efficacy and safety of their prosthetic heart valve products.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Product Type
    3. Market Snapshot, By Technology
    4. Market Snapshot, By Application
    5. Market Snapshot, By Region
  4. Global Prosthetic Heart Valve Devices And Equipment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Rising Prevalence of Heart Valve Diseases
        2. Aging Global Population
        3. Technological Advancements
      2. Restraints
        1. High Cost of Devices and Procedures
        2. Risk of Complications and Reoperation
        3. Stringent Regulatory Approval Processes
      3. Opportunities
        1. Expansion in Emerging Markets
        2. Advancements in Minimally Invasive Procedures
        3. Growing Investments in R&D and Innovation
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Prosthetic Heart Valve Devices And Equipment Market, By Type, 2021 - 2031 (USD Million)
      1. Transcatheter Heart Valve
      2. Tissue Heart Valve
      3. Mechanical Heart Valve
    2. Global Prosthetic Heart Valve Devices And Equipment Market, By Product Type, 2021 - 2031 (USD Million)
      1. Repair Products
      2. Mitral Valve Repair Devices
      3. Tricuspid Valve Repair Devices
    3. Global Prosthetic Heart Valve Devices And Equipment Market, By Technology, 2021 - 2031 (USD Million)
      1. Biological Valve
      2. Decellularized Valve
    4. Global Prosthetic Heart Valve Devices And Equipment Market, By Application, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgery Centres
    5. Global Prosthetic Heart Valve Devices And Equipment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Edwards Lifesciences Corporation
      2. Medtronic plc
      3. Abbott Laboratories
      4. Boston Scientific Corporation
      5. LivaNova PLC
      6. CryoLife Inc.
      7. Braile Biomedica
      8. Colibri Heart Valve, LLC
      9. JenaValve Technology, Inc.
      10. Micro Interventional Devices, Inc.
  7. Analyst Views
  8. Future Outlook of the Market